Rodes Biopharma ApS

CVR 42425990Private limited company (ApS)Virksomhedsrådgivning og anden ledelsesrådgivning (702000)CharlottenlundFounded 28 May 2021

Employees

CVR registry, Jul 2026

Gross profit

3,6M

DKK, annual report 2025

+215,3% on 2024

Result

+1,5M

DKK, annual report 2025

Equity

1,9M

DKK, annual report 2025

Who Is Behind It

Owners

Jens Bo Rode Hansen50% to under 66,7% of capital and votes, since 26 Apr 2022

Gitte Rode50% to under 66,7% of capital and votes, since 26 Apr 2022

Director

Jens Bo Rode Hansensince 1 Jun 2021

Ownership

Jens Bo Rode Hansen
50% to under 66,7% of capital and votessince 26 Apr 2022
Gitte Rode
50% to under 66,7% of capital and votessince 26 Apr 2022

Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.

People

Current (2)

Jens Bo Rode HansenExecutive board since 1 Jun 2021
Gitte RodeBoard of directors since 28 Feb 2022

Founders (1)

Jens Bo Rode HansenFounded 28 May 2021, holds a current role

CVR records founders at incorporation. It does not record whether they are alive or still involved.

Network

CompanyPersonShared by two or more of its peopleThicker lines are ownershipSource: CVR, read 20 Oct 2026. Each current person is followed to their other current roles, at most 10 companies each. Their own people are not drawn.

The Network as a List

Its people and their other companies

Jens Bo Rode Hansen 50% to under 66,7% of capital and votes
- Harryson Holding ApS CVR 46722965, Owner, Executive board
- Koblano Therapeutics ApS CVR 46843703, Executive board, Board of directors
Gitte Rode 50% to under 66,7% of capital and votes
- Rodes Psykologisk Rådgivning CVR 46158385, Partner

Network

Roles Over Time

Jens Bo Rode Hansen: Executive board, 1 Jun 2021 to today.
Gitte Rode: Board of directors, 28 Feb 2022 to today.

1 Jun 2021 to 20 Oct 2026.

Executive board (Direktion)Board of directors (Bestyrelse)Each bar is one role, from its start to its end or today. Bars in a group share one scale. Source: CVR.

Financials

Annual report figures by year, DKK thousands
Metric	2021	2022	2023	2024	2025
Gross profit	68	487	1.774	1.139	3.592
Operating profit	+68	+487	+508	+157	+1.959
Result for the year	+53	+390	+387	+94	+1.503
Equity	93	483	523	495	1.863
Total assets	195	1.029	1.459	1.520	2.462
Employees (average)	1	1	1	2	2

DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2021 covers 7 months (1 Jun to 31 Dec 2021). Changes against it compare periods of different length.

Annual Reports

Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 11 Mar 2026
XHTML
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 25 Jun 2025
XHTML
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 29 Apr 2024
PDF
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 8 May 2023
PDF
Annual report 2021
1 Jun 2021 to 31 Dec 2021, published 10 May 2022
PDF

Changes

All changes

19 Oct 2026
Name change
Rodes Biopharma ApS (CVR 42425990) har skiftet navn fra "Rodes ApS" til "Rodes Biopharma ApS" pr. 19. oktober 2026.

Registration

Address: Hans Bruuns Vej 4
2920 Charlottenlund
Gentofte Municipality
CVR record last changed: 19 Oct 2026
Data read: 20 Oct 2026

Production Units

1 registered in CVR.

Rodes Biopharma ApS
P-number 1027211271Hans Bruuns Vej 4, 2920 Charlottenlund

Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.

Ask About Rodes Biopharma ApS With AI

Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.

Set Up MCP Try the Chat Demo